PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $425,571 | +152.3% | 23,656 | 0.0% | 0.01% | +100.0% |
Q1 2020 | $168,667 | -70.2% | 23,656 | -0.2% | 0.00% | -55.6% |
Q4 2019 | $565,837 | -11.0% | 23,695 | 0.0% | 0.01% | -18.2% |
Q3 2019 | $635,500 | +10.8% | 23,695 | +12.1% | 0.01% | +10.0% |
Q2 2019 | $573,474 | -21.8% | 21,138 | 0.0% | 0.01% | -23.1% |
Q1 2019 | $733,489 | +77.8% | 21,138 | 0.0% | 0.01% | +62.5% |
Q4 2018 | $412,614 | -26.7% | 21,138 | 0.0% | 0.01% | -20.0% |
Q3 2018 | $562,905 | -99.9% | 21,138 | 0.0% | 0.01% | -23.1% |
Q2 2018 | $798,382,000 | +33.5% | 21,138 | +15.4% | 0.01% | +62.5% |
Q1 2018 | $598,168,000 | +68576.0% | 18,315 | +2.4% | 0.01% | -33.3% |
Q4 2017 | $871,000 | -56.4% | 17,885 | -51.6% | 0.01% | 0.0% |
Q3 2017 | $1,996,000 | +3.3% | 36,939 | +7.3% | 0.01% | -7.7% |
Q2 2017 | $1,933,000 | +45.0% | 34,415 | +1.1% | 0.01% | +44.4% |
Q1 2017 | $1,333,000 | +68.3% | 34,025 | -3.6% | 0.01% | +50.0% |
Q4 2016 | $792,000 | -1.2% | 35,298 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $802,000 | -3.7% | 35,298 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $833,000 | +15.7% | 35,298 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $720,000 | -60.0% | 35,298 | +1.0% | 0.01% | -57.1% |
Q4 2015 | $1,798,000 | +26.6% | 34,944 | +4.9% | 0.01% | +40.0% |
Q3 2015 | $1,420,000 | -7.4% | 33,318 | -1.0% | 0.01% | -9.1% |
Q2 2015 | $1,533,000 | +14.2% | 33,648 | -4.8% | 0.01% | +10.0% |
Q1 2015 | $1,342,000 | +42.5% | 35,361 | +6.3% | 0.01% | +42.9% |
Q4 2014 | $942,000 | +29.8% | 33,269 | +15.9% | 0.01% | +40.0% |
Q3 2014 | $726,000 | -13.3% | 28,699 | 0.0% | 0.01% | -16.7% |
Q2 2014 | $837,000 | +198.9% | 28,699 | +165.9% | 0.01% | +200.0% |
Q1 2014 | $280,000 | +0.7% | 10,794 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $278,000 | -1.8% | 10,794 | +1.9% | 0.00% | 0.0% |
Q3 2013 | $283,000 | +5.2% | 10,596 | -3.4% | 0.00% | 0.0% |
Q2 2013 | $269,000 | – | 10,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 170,129 | $3,321,000 | 9.18% |
CADIAN CAPITAL MANAGEMENT, LP | 6,462,605 | $126,150,000 | 5.87% |
Fernwood Investment Management, LLC | 340,263 | $6,642,000 | 4.28% |
Tamarack Advisers, LP | 400,000 | $7,808,000 | 3.18% |
Grace Capital | 279,209 | $5,456,000 | 2.53% |
HIGHLAND CAPITAL MANAGEMENT LP | 1,582,129 | $30,883,000 | 2.37% |
Foresite Capital Management IV, LLC | 250,000 | $4,880,000 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 823,607 | $16,077,000 | 2.18% |
HARVEY CAPITAL MANAGEMENT INC | 164,672 | $3,214,000 | 1.71% |
WISCONSIN CAPITAL MANAGEMENT LLC | 68,549 | $1,338,000 | 1.42% |